Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout. (2019)
Attributed to:
MRC North West Hub for Trials Methodology Research
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1454
PubMed Identifier: 30993686
Publication URI: http://europepmc.org/abstract/MED/30993686
Type: Journal Article/Review
Volume: 106
Parent Publication: Clinical pharmacology and therapeutics
Issue: 3
ISSN: 0009-9236